Global Needle-Free Drug Injection Systems Market Growth 2021-2026
According to this latest study, the 2021 growth of Needle-Free Drug Injection Systems will have significant change from previous year. By the most conservative estimates of global Needle-Free Drug Injection Systems market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Needle-Free Drug Injection Systems market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Needle-Free Drug Injection Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Jet-Based Needle-Free Injectors
Spring-Based Needle-Free Injectors
Laser-Powered Needle-Free Injectors
Vibration-Based Needle-Free Injectors
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals and Clinics
Homecare Settings
Research Laboratories
Pharmaceutical and Biotechnology companies
Other End Users
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Antares Pharma, Inc. (US)
Endo International plc (US)
PharmaJet (U.S)
Bioject Medical Technologies Inc. (U.S)
Medical International Technology, Inc. (U.S)
INJEX Pharma AG (Germany)
National Medical Products Inc. (US)
Valeritas, Inc. (US)
European Pharma Group (Netherland)
PenJet Corporation (U.S)
Crossject SA (France)
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Needle-Free Drug Injection Systems Consumption 2016-2026
2.1.2 Needle-Free Drug Injection Systems Consumption CAGR by Region
2.2 Needle-Free Drug Injection Systems Segment by Type
2.2.1 Jet-Based Needle-Free Injectors
2.2.2 Spring-Based Needle-Free Injectors
2.2.3 Laser-Powered Needle-Free Injectors
2.2.4 Vibration-Based Needle-Free Injectors
2.3 Needle-Free Drug Injection Systems Sales by Type
2.3.1 Global Needle-Free Drug Injection Systems Sales Market Share by Type (2016-2021)
2.3.2 Global Needle-Free Drug Injection Systems Revenue and Market Share by Type (2016-2021)
2.3.3 Global Needle-Free Drug Injection Systems Sale Price by Type (2016-2021)
2.4 Needle-Free Drug Injection Systems Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Homecare Settings
2.4.3 Research Laboratories
2.4.4 Pharmaceutical and Biotechnology companies
2.4.5 Other End Users
2.5 Needle-Free Drug Injection Systems Sales by Application
2.5.1 Global Needle-Free Drug Injection Systems Sale Market Share by Application (2016-2021)
2.5.2 Global Needle-Free Drug Injection Systems Revenue and Market Share by Application (2016-2021)
2.5.3 Global Needle-Free Drug Injection Systems Sale Price by Application (2016-2021)
3 Global Needle-Free Drug Injection Systems by Company
3.1 Global Needle-Free Drug Injection Systems Sales Market Share by Company
3.1.1 Global Needle-Free Drug Injection Systems Sales by Company (2019-2021)
3.1.2 Global Needle-Free Drug Injection Systems Sales Market Share by Company (2019-2021)
3.2 Global Needle-Free Drug Injection Systems Revenue Market Share by Company
3.2.1 Global Needle-Free Drug Injection Systems Revenue by Company (2019-2021)
3.2.2 Global Needle-Free Drug Injection Systems Revenue Market Share by Company (2019-2021)
3.3 Global Needle-Free Drug Injection Systems Sale Price by Company
3.4 Global Manufacturers Needle-Free Drug Injection Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Needle-Free Drug Injection Systems Product Location Distribution
3.4.2 Players Needle-Free Drug Injection Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Needle-Free Drug Injection Systems by Region
4.1 Global Needle-Free Drug Injection Systems by Region
4.1.1 Global Needle-Free Drug Injection Systems Sales by Region
4.1.2 Global Needle-Free Drug Injection Systems Revenue by Region
4.2 Americas Needle-Free Drug Injection Systems Sales Growth
4.3 APAC Needle-Free Drug Injection Systems Sales Growth
4.4 Europe Needle-Free Drug Injection Systems Sales Growth
4.5 Middle East & Africa Needle-Free Drug Injection Systems Sales Growth
5 Americas
5.1 Americas Needle-Free Drug Injection Systems Sales by Country
5.1.1 Americas Needle-Free Drug Injection Systems Sales by Country (2016-2021)
5.1.2 Americas Needle-Free Drug Injection Systems Revenue by Country (2016-2021)
5.2 Americas Needle-Free Drug Injection Systems Sales by Type
5.3 Americas Needle-Free Drug Injection Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Needle-Free Drug Injection Systems Sales by Region
6.1.1 APAC Needle-Free Drug Injection Systems Sales by Region (2016-2021)
6.1.2 APAC Needle-Free Drug Injection Systems Revenue by Region (2016-2021)
6.2 APAC Needle-Free Drug Injection Systems Sales by Type
6.3 APAC Needle-Free Drug Injection Systems Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Needle-Free Drug Injection Systems by Country
7.1.1 Europe Needle-Free Drug Injection Systems Sales by Country (2016-2021)
7.1.2 Europe Needle-Free Drug Injection Systems Revenue by Country (2016-2021)
7.2 Europe Needle-Free Drug Injection Systems Sales by Type
7.3 Europe Needle-Free Drug Injection Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Needle-Free Drug Injection Systems by Country
8.1.1 Middle East & Africa Needle-Free Drug Injection Systems Sales by Country (2016-2021)
8.1.2 Middle East & Africa Needle-Free Drug Injection Systems Revenue by Country (2016-2021)
8.2 Middle East & Africa Needle-Free Drug Injection Systems Sales by Type
8.3 Middle East & Africa Needle-Free Drug Injection Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Needle-Free Drug Injection Systems Distributors
10.3 Needle-Free Drug Injection Systems Customer
11 Global Needle-Free Drug Injection Systems Market Forecast
11.1 Global Needle-Free Drug Injection Systems Forecast by Region
11.1.1 Global Needle-Free Drug Injection Systems Forecast by Regions (2021-2026)
11.2.2 Global Needle-Free Drug Injection Systems Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Needle-Free Drug Injection Systems Forecast by Type
11.7 Global Needle-Free Drug Injection Systems Forecast by Application
12 Key Players Analysis
12.1 Antares Pharma, Inc. (US)
12.1.1 Antares Pharma, Inc. (US) Company Information
12.1.2 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product Offered
12.1.3 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Antares Pharma, Inc. (US) Main Business Overview
12.1.5 Antares Pharma, Inc. (US) Latest Developments
12.2 Endo International plc (US)
12.2.1 Endo International plc (US) Company Information
12.2.2 Endo International plc (US) Needle-Free Drug Injection Systems Product Offered
12.2.3 Endo International plc (US) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Endo International plc (US) Main Business Overview
12.2.5 Endo International plc (US) Latest Developments
12.3 PharmaJet (U.S)
12.3.1 PharmaJet (U.S) Company Information
12.3.2 PharmaJet (U.S) Needle-Free Drug Injection Systems Product Offered
12.3.3 PharmaJet (U.S) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 PharmaJet (U.S) Main Business Overview
12.3.5 PharmaJet (U.S) Latest Developments
12.4 Bioject Medical Technologies Inc. (U.S)
12.4.1 Bioject Medical Technologies Inc. (U.S) Company Information
12.4.2 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product Offered
12.4.3 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Bioject Medical Technologies Inc. (U.S) Main Business Overview
12.4.5 Bioject Medical Technologies Inc. (U.S) Latest Developments
12.5 Medical International Technology, Inc. (U.S)
12.5.1 Medical International Technology, Inc. (U.S) Company Information
12.5.2 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product Offered
12.5.3 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Medical International Technology, Inc. (U.S) Main Business Overview
12.5.5 Medical International Technology, Inc. (U.S) Latest Developments
12.6 INJEX Pharma AG (Germany)
12.6.1 INJEX Pharma AG (Germany) Company Information
12.6.2 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product Offered
12.6.3 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 INJEX Pharma AG (Germany) Main Business Overview
12.6.5 INJEX Pharma AG (Germany) Latest Developments
12.7 National Medical Products Inc. (US)
12.7.1 National Medical Products Inc. (US) Company Information
12.7.2 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product Offered
12.7.3 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 National Medical Products Inc. (US) Main Business Overview
12.7.5 National Medical Products Inc. (US) Latest Developments
12.8 Valeritas, Inc. (US)
12.8.1 Valeritas, Inc. (US) Company Information
12.8.2 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product Offered
12.8.3 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Valeritas, Inc. (US) Main Business Overview
12.8.5 Valeritas, Inc. (US) Latest Developments
12.9 European Pharma Group (Netherland)
12.9.1 European Pharma Group (Netherland) Company Information
12.9.2 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product Offered
12.9.3 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 European Pharma Group (Netherland) Main Business Overview
12.9.5 European Pharma Group (Netherland) Latest Developments
12.10 PenJet Corporation (U.S)
12.10.1 PenJet Corporation (U.S) Company Information
12.10.2 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product Offered
12.10.3 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 PenJet Corporation (U.S) Main Business Overview
12.10.5 PenJet Corporation (U.S) Latest Developments
12.11 Crossject SA (France)
12.11.1 Crossject SA (France) Company Information
12.11.2 Crossject SA (France) Needle-Free Drug Injection Systems Product Offered
12.11.3 Crossject SA (France) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Crossject SA (France) Main Business Overview
12.11.5 Crossject SA (France) Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Needle-Free Drug Injection Systems Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Jet-Based Needle-Free Injectors
Table 3. Major Players of Spring-Based Needle-Free Injectors
Table 4. Major Players of Laser-Powered Needle-Free Injectors
Table 5. Major Players of Vibration-Based Needle-Free Injectors
Table 6. Global Needle-Free Drug Injection Systems Sales by Type (2016-2021) & (K Units)
Table 7. Global Needle-Free Drug Injection Systems Sales Market Share by Type (2016-2021)
Table 8. Global Needle-Free Drug Injection Systems Revenue by Type (2016-2021) & ($ million)
Table 9. Global Needle-Free Drug Injection Systems Revenue Market Share by Type (2016-2021)
Table 10. Global Needle-Free Drug Injection Systems Sale Price by Type (2016-2021)
Table 11. Global Needle-Free Drug Injection Systems Sales by Application (2016-2021) & (K Units)
Table 12. Global Needle-Free Drug Injection Systems Sales Market Share by Application (2016-2021)
Table 13. Global Needle-Free Drug Injection Systems Value by Application (2016-2021)
Table 14. Global Needle-Free Drug Injection Systems Revenue Market Share by Application (2016-2021)
Table 15. Global Needle-Free Drug Injection Systems Sale Price by Application (2016-2021)
Table 16. Global Needle-Free Drug Injection Systems Sales by Company (2019-2021) & (K Units)
Table 17. Global Needle-Free Drug Injection Systems Sales Market Share by Company (2019-2021)
Table 18. Global Needle-Free Drug Injection Systems Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Needle-Free Drug Injection Systems Revenue Market Share by Company (2019-2021)
Table 20. Global Needle-Free Drug Injection Systems Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Needle-Free Drug Injection Systems Producing Area Distribution and Sales Area
Table 22. Players Needle-Free Drug Injection Systems Products Offered
Table 23. Needle-Free Drug Injection Systems Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Needle-Free Drug Injection Systems Sales by Region (2016-2021) (K Units)
Table 27. Global Needle-Free Drug Injection Systems Sales Market Share by Region (2016-2021)
Table 28. Global Needle-Free Drug Injection Systems Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Needle-Free Drug Injection Systems Revenue Market Share by Region (2016-2021)
Table 30. Americas Needle-Free Drug Injection Systems Sales by Country (2016-2021) & (K Units)
Table 31. Americas Needle-Free Drug Injection Systems Sales Market Share by Country (2016-2021)
Table 32. Americas Needle-Free Drug Injection Systems Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Needle-Free Drug Injection Systems Revenue Market Share by Country (2016-2021)
Table 34. Americas Needle-Free Drug Injection Systems Sales by Type (2016-2021) & (K Units)
Table 35. Americas Needle-Free Drug Injection Systems Sales Market Share by Type (2016-2021)
Table 36. Americas Needle-Free Drug Injection Systems Sales by Application (2016-2021) & (K Units)
Table 37. Americas Needle-Free Drug Injection Systems Sales Market Share by Application (2016-2021)
Table 38. APAC Needle-Free Drug Injection Systems Sales by Region (2016-2021) & (K Units)
Table 39. APAC Needle-Free Drug Injection Systems Sales Market Share by Region (2016-2021)
Table 40. APAC Needle-Free Drug Injection Systems Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Needle-Free Drug Injection Systems Revenue Market Share by Region (2016-2021)
Table 42. APAC Needle-Free Drug Injection Systems Sales by Type (2016-2021) & (K Units)
Table 43. APAC Needle-Free Drug Injection Systems Sales Market Share by Type (2016-2021)
Table 44. APAC Needle-Free Drug Injection Systems Sales by Application (2016-2021) & (K Units)
Table 45. APAC Needle-Free Drug Injection Systems Sales Market Share by Application (2016-2021)
Table 46. Europe Needle-Free Drug Injection Systems Sales by Country (2016-2021) & (K Units)
Table 47. Europe Needle-Free Drug Injection Systems Sales Market Share by Country (2016-2021)
Table 48. Europe Needle-Free Drug Injection Systems Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Needle-Free Drug Injection Systems Revenue Market Share by Country (2016-2021)
Table 50. Europe Needle-Free Drug Injection Systems Sales by Type (2016-2021) & (K Units)
Table 51. Europe Needle-Free Drug Injection Systems Sales Market Share by Type (2016-2021)
Table 52. Europe Needle-Free Drug Injection Systems Sales by Application (2016-2021) & (K Units)
Table 53. Europe Needle-Free Drug Injection Systems Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Needle-Free Drug Injection Systems Sales by Country (2016-2021) & (K Units)
Table 55. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Needle-Free Drug Injection Systems Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Needle-Free Drug Injection Systems Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Needle-Free Drug Injection Systems Sales by Type (2016-2021) & (K Units)
Table 59. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Needle-Free Drug Injection Systems Sales by Application (2016-2021) & (K Units)
Table 61. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Needle-Free Drug Injection Systems
Table 63. Key Application and Potential Industries of Needle-Free Drug Injection Systems
Table 64. Key Challenges of Needle-Free Drug Injection Systems
Table 65. Key Trends of Needle-Free Drug Injection Systems
Table 66. Needle-Free Drug Injection Systems Distributors List
Table 67. Needle-Free Drug Injection Systems Customer List
Table 68. Global Needle-Free Drug Injection Systems Sales Forecast by Region (2021-2026) & (K Units)
Table 69. Global Needle-Free Drug Injection Systems Consumption Market Forecast by Region
Table 70. Global Needle-Free Drug Injection Systems Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Needle-Free Drug Injection Systems Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Needle-Free Drug Injection Systems Sales Forecast by Country (2021-2026) & (K Units)
Table 73. Americas Needle-Free Drug Injection Systems Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Needle-Free Drug Injection Systems Sales Forecast by Region (2021-2026) & (K Units)
Table 75. APAC Needle-Free Drug Injection Systems Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Needle-Free Drug Injection Systems Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Europe Needle-Free Drug Injection Systems Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Needle-Free Drug Injection Systems Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Middle East & Africa Needle-Free Drug Injection Systems Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Needle-Free Drug Injection Systems Sales Forecast by Type (2021-2026) & (K Units)
Table 81. Global Needle-Free Drug Injection Systems Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Needle-Free Drug Injection Systems Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Needle-Free Drug Injection Systems Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Needle-Free Drug Injection Systems Sales Forecast by Application (2021-2026) & (K Units)
Table 85. Global Needle-Free Drug Injection Systems Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Needle-Free Drug Injection Systems Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Needle-Free Drug Injection Systems Revenue Market Share Forecast by Application (2021-2026)
Table 88. Antares Pharma, Inc. (US) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 89. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product Offered
Table 90. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 91. Antares Pharma, Inc. (US) Main Business
Table 92. Antares Pharma, Inc. (US) Latest Developments
Table 93. Endo International plc (US) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 94. Endo International plc (US) Needle-Free Drug Injection Systems Product Offered
Table 95. Endo International plc (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 96. Endo International plc (US) Main Business
Table 97. Endo International plc (US) Latest Developments
Table 98. PharmaJet (U.S) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 99. PharmaJet (U.S) Needle-Free Drug Injection Systems Product Offered
Table 100. PharmaJet (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 101. PharmaJet (U.S) Main Business
Table 102. PharmaJet (U.S) Latest Developments
Table 103. Bioject Medical Technologies Inc. (U.S) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 104. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product Offered
Table 105. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 106. Bioject Medical Technologies Inc. (U.S) Main Business
Table 107. Bioject Medical Technologies Inc. (U.S) Latest Developments
Table 108. Medical International Technology, Inc. (U.S) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 109. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product Offered
Table 110. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 111. Medical International Technology, Inc. (U.S) Main Business
Table 112. Medical International Technology, Inc. (U.S) Latest Developments
Table 113. INJEX Pharma AG (Germany) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 114. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product Offered
Table 115. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 116. INJEX Pharma AG (Germany) Main Business
Table 117. INJEX Pharma AG (Germany) Latest Developments
Table 118. National Medical Products Inc. (US) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 119. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product Offered
Table 120. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 121. National Medical Products Inc. (US) Main Business
Table 122. National Medical Products Inc. (US) Latest Developments
Table 123. Valeritas, Inc. (US) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 124. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product Offered
Table 125. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 126. Valeritas, Inc. (US) Main Business
Table 127. Valeritas, Inc. (US) Latest Developments
Table 128. European Pharma Group (Netherland) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 129. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product Offered
Table 130. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 131. European Pharma Group (Netherland) Main Business
Table 132. European Pharma Group (Netherland) Latest Developments
Table 133. PenJet Corporation (U.S) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 134. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product Offered
Table 135. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 136. PenJet Corporation (U.S) Main Business
Table 137. PenJet Corporation (U.S) Latest Developments
Table 138. Crossject SA (France) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 139. Crossject SA (France) Needle-Free Drug Injection Systems Product Offered
Table 140. Crossject SA (France) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 141. Crossject SA (France) Main Business
Table 142. Crossject SA (France) Latest Developments
List of Figures
Figure 1. Picture of Needle-Free Drug Injection Systems
Figure 2. Needle-Free Drug Injection Systems Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Needle-Free Drug Injection Systems Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Needle-Free Drug Injection Systems Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Needle-Free Drug Injection Systems Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Jet-Based Needle-Free Injectors
Figure 10. Product Picture of Spring-Based Needle-Free Injectors
Figure 11. Product Picture of Laser-Powered Needle-Free Injectors
Figure 12. Product Picture of Vibration-Based Needle-Free Injectors
Figure 13. Global Needle-Free Drug Injection Systems Sales Market Share by Type in 2020
Figure 14. Global Needle-Free Drug Injection Systems Revenue Market Share by Type (2016-2021)
Figure 15. Needle-Free Drug Injection Systems Consumed in Hospitals and Clinics
Figure 16. Global Needle-Free Drug Injection Systems Market: Hospitals and Clinics (2016-2021) & (K Units)
Figure 17. Needle-Free Drug Injection Systems Consumed in Homecare Settings
Figure 18. Global Needle-Free Drug Injection Systems Market: Homecare Settings (2016-2021) & (K Units)
Figure 19. Needle-Free Drug Injection Systems Consumed in Research Laboratories
Figure 20. Global Needle-Free Drug Injection Systems Market: Research Laboratories (2016-2021) & (K Units)
Figure 21. Needle-Free Drug Injection Systems Consumed in Pharmaceutical and Biotechnology companies
Figure 22. Global Needle-Free Drug Injection Systems Market: Pharmaceutical and Biotechnology companies (2016-2021) & (K Units)
Figure 23. Needle-Free Drug Injection Systems Consumed in Other End Users
Figure 24. Global Needle-Free Drug Injection Systems Market: Other End Users (2016-2021) & (K Units)
Figure 25. Global Needle-Free Drug Injection Systems Sales Market Share by Application (2016-2021)
Figure 26. Global Needle-Free Drug Injection Systems Revenue Market Share by Application in 2020
Figure 27. Needle-Free Drug Injection Systems Revenue Market by Company in 2020 ($ Million)
Figure 28. Global Needle-Free Drug Injection Systems Revenue Market Share by Company in 2020
Figure 29. Global Needle-Free Drug Injection Systems Sales Market Share by Regions (2016-2021)
Figure 30. Global Needle-Free Drug Injection Systems Revenue Market Share by Region in 2020
Figure 31. Americas Needle-Free Drug Injection Systems Sales 2016-2021 (K Units)
Figure 32. Americas Needle-Free Drug Injection Systems Revenue 2016-2021 ($ Millions)
Figure 33. APAC Needle-Free Drug Injection Systems Sales 2016-2021 (K Units)
Figure 34. APAC Needle-Free Drug Injection Systems Revenue 2016-2021 ($ Millions)
Figure 35. Europe Needle-Free Drug Injection Systems Sales 2016-2021 (K Units)
Figure 36. Europe Needle-Free Drug Injection Systems Revenue 2016-2021 ($ Millions)
Figure 37. Middle East & Africa Needle-Free Drug Injection Systems Sales 2016-2021 (K Units)
Figure 38. Middle East & Africa Needle-Free Drug Injection Systems Revenue 2016-2021 ($ Millions)
Figure 39. Americas Needle-Free Drug Injection Systems Sales Market Share by Country in 2020
Figure 40. Americas Needle-Free Drug Injection Systems Revenue Market Share by Country in 2020
Figure 41. Americas Needle-Free Drug Injection Systems Sales Market Share by Type in 2020
Figure 42. Americas Needle-Free Drug Injection Systems Sales Market Share by Application in 2020
Figure 43. United States Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 44. Canada Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 45. Mexico Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 46. Brazil Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 47. APAC Needle-Free Drug Injection Systems Sales Market Share by Region in 2020
Figure 48. APAC Needle-Free Drug Injection Systems Revenue Market Share by Regions in 2020
Figure 49. APAC Needle-Free Drug Injection Systems Sales Market Share by Type in 2020
Figure 50. APAC Needle-Free Drug Injection Systems Sales Market Share by Application in 2020
Figure 51. China Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 52. Japan Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 53. Korea Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 54. Southeast Asia Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 55. India Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 56. Australia Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 57. Europe Needle-Free Drug Injection Systems Sales Market Share by Country in 2020
Figure 58. Europe Needle-Free Drug Injection Systems Revenue Market Share by Country in 2020
Figure 59. Europe Needle-Free Drug Injection Systems Sales Market Share by Type in 2020
Figure 60. Europe Needle-Free Drug Injection Systems Sales Market Share by Application in 2020
Figure 61. Germany Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 62. France Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 63. UK Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 64. Italy Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 65. Russia Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 66. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Country in 2020
Figure 67. Middle East & Africa Needle-Free Drug Injection Systems Revenue Market Share by Country in 2020
Figure 68. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Type in 2020
Figure 69. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Application in 2020
Figure 70. Egypt Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 71. South Africa Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 72. Israel Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 73. Turkey Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 74. GCC Country Needle-Free Drug Injection Systems Revenue Growth 2016-2021 ($ Millions)
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
